Frelinger J G, Shigeta M, Infante A J, Nelson P A, Pierres M, Fathman C G
J Exp Med. 1984 Mar 1;159(3):704-15. doi: 10.1084/jem.159.3.704.
Monoclonal antibodies (mAb) were used to inhibit the proliferation of antigen-reactive (C57BL6/J X A/J)F1 restricted T cell clones. We have been able to subdivide these F1 restricted T cell clones into two groups: one of which recognizes the A alpha k A beta b molecule and the other group which recognizes the A alpha b A beta k molecule. Using clones with defined reactivities, we could assign the reactivities of monoclonals to the A alpha or A beta chains. By immunoprecipitation and two-dimensional analysis of Ia molecules from F1 spleen cells, we could independently map the reactivities of the mAb as being determined by the A alpha or A beta chain. To date, these two methods of chain localization of the antibody reactivity have agreed. Further, the differential blocking of the A alpha k A beta b restricted T cell clones suggests that there exists more than one restriction site per Ia molecule. Increasing the number of possible functional Ia restriction sites, either through combinatorial association of alpha and beta chains or by using more than one site per molecule, should increase the number of ways Ia molecules can function in antigen presentation.
单克隆抗体(mAb)被用于抑制抗原反应性(C57BL6/J×A/J)F1限制的T细胞克隆的增殖。我们已能够将这些F1限制的T细胞克隆细分为两组:一组识别Aαk Aβb分子,另一组识别Aαb Aβk分子。使用具有明确反应性的克隆,我们可以将单克隆抗体的反应性归属于Aα或Aβ链。通过对F1脾细胞Ia分子进行免疫沉淀和二维分析,我们能够独立地将单克隆抗体的反应性定位为由Aα或Aβ链所决定。迄今为止,这两种抗体反应性链定位方法的结果是一致的。此外,对Aαk Aβb限制的T细胞克隆的差异阻断表明,每个Ia分子存在不止一个限制位点。通过α链和β链的组合关联或通过每个分子使用不止一个位点来增加可能的功能性Ia限制位点的数量,应该会增加Ia分子在抗原呈递中发挥作用的方式的数量。